Clinical presentation, diagnosis and staging of cholangiocarcinoma-Reference-Cited by-同舟云学术

Clinical presentation, diagnosis and staging of cholangiocarcinoma

Published:2019-03-25 Issue:S1 Volume:39 Page:98-107
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Forner Alejandro¹^ORCID,Vidili Gianpaolo²^ORCID,Rengo Marco³^ORCID,Bujanda Luis⁴^ORCID,Ponz‐Sarvisé Mariano⁵^ORCID,Lamarca Angela⁶⁷^ORCID

Affiliation:

1. Liver Unit, Barcelona Clinic Liver Cancer Group, Hospital Clínic Barcelona, August Pi i Sunyer Biomedical Research Institute, CIBERehd University of Barcelona Barcelona Spain

2. Department of Medical, Surgical and Experimental Sciences University of Sassari Sassari Italy

3. Academic Diagnostic Imaging Division - I.C.O.T. Hospital University of Rome “Sapienza” Latina Italy

4. Department of Gastroenterology, Hospital Donostia/Instituto Biodonostia. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd). Universidad del País Vasco (UPV/EHU) San Sebastian Spain

5. Gastrointestinal Oncology Unit, Clinica Universidad de Navarra, Programa Tumores Solidos y biomarcadrores CIMA, Universidad de Navarra Pamplona Spain

6. Department of Medical Oncology The Christie NHS Foundation Trust Manchester UK

7. Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health University of Manchester Manchester UK

Funder

American Society of Clinical Oncology

Conquer Cancer Foundation

Cholangiocarcinoma Foundation

Christie Charity

European Cooperation in Science and Technology

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14086

Reference64 articles.

1. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

2. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

3. 18F‐fluorodeoxyglucose positron emission tomography (18FDG‐PET) for patients with biliary tract cancer: systematic review and meta‐analysis;Lamarca A;J Hepatol,2019

4. Surgical Outcomes of the Mass-Forming plus Periductal Infiltrating Types of Intrahepatic Cholangiocarcinoma: A Comparative Study with the Typical Mass-Forming Type of Intrahepatic Cholangiocarcinoma

5. Intrahepatic Cholangiocarcinoma

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: From palliative to potentially curative – the advent of immunotherapy providing hope to advanced gallbladder adenocarcinoma;Frontiers in Immunology;2024-02-02

2. Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation;Pharmaceuticals;2024-02-02

3. The role of durvalumab in the treatment of biliary tract tumors;Meditsinskiy sovet = Medical Council;2024-01-18

4. Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma;Cancer Medicine;2024-01-11

5. Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing;Cancer Treatment Reviews;2024-01